Investor
Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (CSE: $PLTH.C)
(CSE: $TER.C) (CSE: $TGIF.C) (TSX: $ACB.TO) (NYSE: $ACB) (OTC:
$OWPC)
Delta, Kelowna, BC –October 22, 2019 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/10221PLTH-TER-TGIF-ACB-OWPC.asp
Good afternoon and welcome to another episode of
Investorideas.com "Potcast" featuring cannabis news, stocks to watch
as well as insights from thought leaders and experts
In today’s
podcast we look at a few of today’s early announcements.
Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNHF) announced today that it has launched a new beverage brand,
Elysium, a refreshing THC-infused line of low-calorie flavored sparkling water.
"Elysium
marks our first step into the exciting THC beverage space. We've created and
perfected a sparkling water beverage based on both customer demand and market
trends. This low-calorie refreshing drink with zero added sugar was designed to
be a fast-acting alternative without the guilt, the perfect micro-dosing
beverage," said Bob Groesbeck Co-CEO of Planet 13. "Our expanded
production facility will enable us to increase production of our top selling
TRENDI line and begin production of Elysium and our highly anticipated edibles
lines Dreamland Chocolates and HaHa Gummies. Customers will be able to watch
these brands being manufactured behind glass. Increased sales of inhouse brands
will drive margin expansion and ultimately shareholder value."
Elysium
is a line of flavored sparkling beverages available in five flavours: Valencia
Orange, Persian Lime, Eureka Lemon, Wild Berry, and Ruby Red Grapefruit. All
flavors are low calorie, zero sugar using all-natural fruit flavourings and
designed for an uplifting high.
TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) today announced that it has received an amendment to its
license from Health Canada to allow it to sell cannabis extracts, topicals and
edibles from its EU-GMP certified facility in Mississauga, Ontario. Sales of
TerrAscend's new product formats will begin in December, pending Health Canada
authorization. The company submitted 15 SKUs to Health Canada, including
edibles, vape pens, and cartridges, to be authorized for launch this year. In
addition, the company plans on submitting an expanded set of SKUs in the coming
months.
"The
addition of cannabis derivatives to our product line enables TerrAscend to
better meet the needs of patients and customers, who demand safe, standardized
products," said Michael Nashat, TerrAscend's CEO. "This approval also
paves the way to bring our US brands and formulations to the Canadian
market."
1933 Industries Inc. (CSE: TGIF) (OTCQX: TGIFF), reported on the Company's most successful brand launch
to date.
Following
a 30-day exclusive campaign with one of Nevada's largest dispensary retailers,
luxury brand Blonde™ Cannabis made its mark in the state by selling out of
every product during its debut. While the Blonde™ brand originated in Los
Angeles, California, Nevada was selected for its launch in partnership with
1933 Industries' subsidiary, Alternative Medicine Association (AMA).
"Blonde™
has taken Las Vegas by storm and we could not be more excited about this
relationship", remarked Ms. Ester Vigil, President of 1933 Industries.
"The positive feedback from consumers has been overwhelming. Blonde™ has
been developed as a premium lifestyle product, connecting with both new and
discerning, quality-savvy consumers looking for remarkable experiences."
Blonde™ cannabis flower, pre-rolls, live resin vape pens and cartridges will be
available for order as of today via licensed dispensaries.
The
partnership with Blonde™ will continue in California, once the Company
completes the renovation of the Green Spectrum facility and sets up its own
extraction equipment (news release dated August 15, 2019). "The team
behind Blonde™ are adept marketers and branders and will be lending their
expertise as we build a house of brands in Nevada, California and in other
legal states across the US", added Ms. Vigil. "We continue to attract
top name brands to our portfolio due to our reputation for producing quality
products that comply with the strictest regulations in the country."
"The
buzz about Blonde™ has met and surpassed our expectations. We knew that
launching a cannabis brand in a crowded marketplace would require key
differentiators based not only on quality cannabis and sophisticated branding
but also on a healthy lifestyle and culture that respects the plant. We have an
opportunity here to inspire, educate and combat the stigma around cannabis. We
are excited to launch in California next month and to continue to collaborate
with 1933 Industries as we build our brand," said Mr. Tim Gavin,
Co-Founder of Blonde™.
EnWave Corporation (TSX-V:ENW) (OTC: NWVCF) reported today that EnWave and Aurora Cannabis Inc. (TSX: ACB) (NYSE: ACB) have signed an exclusive, royalty-bearing
commercial license agreement with sub-licensing rights to use the Company’s
proprietary Radiant Energy Vacuum (“REV™”) dehydration technology for the
drying of cannabis in Australia.
Aurora
will hold an exclusive master license for the drying of cannabis using REV™ in
Australia and will work closely with EnWave to pursue sub-licensing
opportunities. If certain minimum commercialization requirements are met,
Aurora will receive an undisclosed share of royalties derived from any cannabis
product dried with REV™ technology by sub-licensees in Australia.
Concurrently
with the signing of the Agreement, EnWave and Aurora have signed a
royalty-bearing sublicense with Cann
Group Limited (ASX: CAN), Australia’s first Medical Cannabis
Cultivation Licensee. The Sublicense
grants Cann Group the right to use EnWave’s REVTM technology to dry
cannabis in Australia. Pursuant to the Sublicense, Cann Group has signed an
equipment purchase agreement to obtain a 10kW REV™ machine to initiate
commercial production.
The
Sublicense is the first sublicense granted by Aurora and EnWave and the fifth
royalty-bearing commercial license agreement signed by EnWave to dry cannabis
using its proprietary dehydration technology.
One World Pharma
Inc. (OTC: OWPC) announced that it has entered into an exclusive,
multi-year agreement with the WALA POPAYAN Co-operative, a highly skilled
agrarian community in the Colombian Andes to collaborate in the cultivation and
refinement of hemp-derived ingredients.
The
agreement creates a partnership in which OWP blends the ancestral techniques of
the Nasa people with modern technology, registered plant genetics and
international standard operating procedures. The collaboration creates a true
partnership that is expected to maximize the opportunity to grow in one of the
most ideal climates for agriculture in the world. It allows for cultivation of
hemp on the lands owned by the indigenous community.
OWP
will supply the co-op with registered genetics in the form of seeds or
plantlets to grow hemp and non-psychoactive cannabis. Under this agreement, OWP
will advise the co-op on best practices in cultivation, harvesting and
processing of the raw material. The agreement also provides for OWP to purchase
the raw biomass produced under this agreement upon meeting quality control
standards and lab testing. One World Pharma intends to then refine the biomass
at its state-of-the-art facility for export. The hemp-derived ingredients are
expected to be used in Consumer Packaged Goods (CPG) and Over The Counter (OTC)
products being manufactured worldwide.
“One
World Pharma has been extraordinary to our people and the opportunity to
partner with such a visionary company will be outstanding,” stated Ariel Huetio
Prieto, the founder and the legal representative of the co-op. “The technology
and cultivation methods that One World Pharma brings are phenomenal. More than
anything, we are working together as partners to offer a better life for our
people, and for all of Colombia.”
“It
is our mission to partner with the local indigenous communities and small
farmers to produce high quality hemp ingredients for international sale. We
expect this partnership will provide the indigenous community with the ability
to participate in the global supply chain. Our process is a holistic approach
that is expected to create a thriving local economy while generating
significant revenue for our shareholders,” stated Craig Ellins, CEO of One
World Pharma.
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement to
buy products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also
available on iTunes, Spotify, Google
Play Music, Stitcher, Spreaker, YouTube
via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big
Investing Ideas Investorideas.com is a recognized news source
publishing third party news, research and original financial content. Learn
about investing in stocks and sector trends with our news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas Potcasts
Cannabis News and Stocks on the Move podcast and column, Cleantech and
Climate Change , Exploring Mining
the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
